Intellia Therapeutics Inc’s recently made public that its President and CEO LEONARD JOHN M unloaded Company’s shares for reported $0.31 million on Jan 05 ’26. In the deal valued at $9.21 per share,34,146 shares were sold. As a result of this transaction, LEONARD JOHN M now holds 1,013,339 shares worth roughly $10.52 million.
Then, Schultes Birgit C sold 8,508 shares, generating $78,359 in total proceeds. Upon selling the shares at $9.21, the EVP, Chief Scientific Officer now owns 98,533 shares.
Before that, BASTA JAMES sold 10,397 shares. Intellia Therapeutics Inc shares valued at $95,756 were divested by the EVP, General Counsel at a price of $9.21 per share. As a result of the transaction, BASTA JAMES now holds 101,528 shares, worth roughly $1.05 million.
Wolfe Research downgraded its Intellia Therapeutics Inc [NTLA] rating to a Peer perform from a an Outperform in a research note published recently. A number of analysts have revised their coverage, including Evercore ISI’s analysts, who decreased its forecast for the stock in mid November from “an Outperform” to “an In-line”. JP Morgan also remained covering NTLA and has decreased its forecast on November 07, 2025 with a “an Underweight” recommendation from previously “Neutral” rating. RBC Capital Mkts revised its rating on October 28, 2025. It rated NTLA as “a Sector perform” which previously was an “an Outperform”.
Price Performance Review of NTLA
On Monday, Intellia Therapeutics Inc [NASDAQ:NTLA] saw its stock fall -1.33% to $10.38. Over the last five days, the stock has gained 12.70%. Intellia Therapeutics Inc shares have fallen nearly -16.76% since the year began. Nevertheless, the stocks have risen 15.46% over the past one year.
How much short interest is there in Intellia Therapeutics Inc?
A steep rise in short interest was recorded in Intellia Therapeutics Inc stocks on 2025-12-15, growing by 0.34 million shares to a total of 40.58 million shares. Yahoo Finance data shows the prior-month short interest on 2025-11-14 was 40.24 million shares. There was a rise of 0.84%, which implies that there is a positive sentiment for the stock.
